+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neuromyelitis Optica Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 104 Pages
  • May 2022
  • Region: Global
  • Prof Research
  • ID: 5596567
Description Jump to:
This report describes the global market size of Neuromyelitis Optica Drug from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027.

For the geography segment, regional supply, demand, major players, price is presented from 2017 to 2027.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA

The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Neuromyelitis Optica Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Acute attack
  • Remission prophylactic treatment

Types Segment:

  • Glucocorticoids
  • Immunoglobulin
  • Other

Companies Covered:

  • Pfizer
  • Fresenius
  • TEVA
  • Sandoz
  • Intas
  • Gyjtrs
  • Nang Kuang
  • Tianjin Kingyork
  • Baxter
  • CSL

Base Year: 2022
Historical Data: from 2017 to 2021
Forecast Data: from 2022 to 2027


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
4. Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Neuromyelitis Optica Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Neuromyelitis Optica Drug Market in North America (2017-2027)
8.1 Neuromyelitis Optica Drug Market Size
8.2 Neuromyelitis Optica Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Neuromyelitis Optica Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Neuromyelitis Optica Drug Market in South America (2017-2027)
9.1 Neuromyelitis Optica Drug Market Size
9.2 Neuromyelitis Optica Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Neuromyelitis Optica Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Neuromyelitis Optica Drug Market in Asia & Pacific (2017-2027)
10.1 Neuromyelitis Optica Drug Market Size
10.2 Neuromyelitis Optica Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Neuromyelitis Optica Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Neuromyelitis Optica Drug Market in Europe (2017-2027)
11.1 Neuromyelitis Optica Drug Market Size
11.2 Neuromyelitis Optica Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Neuromyelitis Optica Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Neuromyelitis Optica Drug Market in MEA (2017-2027)
12.1 Neuromyelitis Optica Drug Market Size
12.2 Neuromyelitis Optica Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Neuromyelitis Optica Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Neuromyelitis Optica Drug Market (2017-2022)
13.1 Neuromyelitis Optica Drug Market Size
13.2 Neuromyelitis Optica Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Neuromyelitis Optica Drug Market Size by Type
Chapter 14 Global Neuromyelitis Optica Drug Market Forecast (2022-2027)
14.1 Neuromyelitis Optica Drug Market Size Forecast
14.2 Neuromyelitis Optica Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Neuromyelitis Optica Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Neuromyelitis Optica Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.2 Fresenius
15.2.1 Company Profile
15.2.2 Main Business and Neuromyelitis Optica Drug Information
15.2.3 SWOT Analysis of Fresenius
15.2.4 Fresenius Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.3 TEVA
15.3.1 Company Profile
15.3.2 Main Business and Neuromyelitis Optica Drug Information
15.3.3 SWOT Analysis of TEVA
15.3.4 TEVA Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.4 Sandoz
15.4.1 Company Profile
15.4.2 Main Business and Neuromyelitis Optica Drug Information
15.4.3 SWOT Analysis of Sandoz
15.4.4 Sandoz Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.5 Intas
15.5.1 Company Profile
15.5.2 Main Business and Neuromyelitis Optica Drug Information
15.5.3 SWOT Analysis of Intas
15.5.4 Intas Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.6 Gyjtrs
15.6.1 Company Profile
15.6.2 Main Business and Neuromyelitis Optica Drug Information
15.6.3 SWOT Analysis of Gyjtrs
15.6.4 Gyjtrs Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.7 Nang Kuang
15.7.1 Company Profile
15.7.2 Main Business and Neuromyelitis Optica Drug Information
15.7.3 SWOT Analysis of Nang Kuang
15.7.4 Nang Kuang Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.8 Tianjin Kingyork
15.8.1 Company Profile
15.8.2 Main Business and Neuromyelitis Optica Drug Information
15.8.3 SWOT Analysis of Tianjin Kingyork
15.8.4 Tianjin Kingyork Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.9 Baxter
15.9.1 Company Profile
15.9.2 Main Business and Neuromyelitis Optica Drug Information
15.9.3 SWOT Analysis of Baxter
15.9.4 Baxter Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
15.10 CSL
15.10.1 Company Profile
15.10.2 Main Business and Neuromyelitis Optica Drug Information
15.10.3 SWOT Analysis of CSL
15.10.4 CSL Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2017-2022)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Neuromyelitis Optica Drug Report
Table Data Sources of Neuromyelitis Optica Drug Report
Table Major Assumptions of Neuromyelitis Optica Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Neuromyelitis Optica Drug Picture
Table Neuromyelitis Optica Drug Classification
Table Neuromyelitis Optica Drug Applications
Table Drivers of Neuromyelitis Optica Drug Market
Table Restraints of Neuromyelitis Optica Drug Market
Table Opportunities of Neuromyelitis Optica Drug Market
Table Threats of Neuromyelitis Optica Drug Market
Table Covid-19 Impact For Neuromyelitis Optica Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Neuromyelitis Optica Drug
Table Cost Structure Analysis of Neuromyelitis Optica Drug
Table Key End Users
Table Latest News of Neuromyelitis Optica Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Neuromyelitis Optica Drug Market
Table Policy of Neuromyelitis Optica Drug Market
Table 2017-2027 North America Neuromyelitis Optica Drug Market Size
Figure 2017-2027 North America Neuromyelitis Optica Drug Market Size and CAGR
Table 2017-2027 North America Neuromyelitis Optica Drug Market Size by Application
Table 2017-2022 North America Neuromyelitis Optica Drug Key Players Revenue
Table 2017-2022 North America Neuromyelitis Optica Drug Key Players Market Share
Table 2017-2027 North America Neuromyelitis Optica Drug Market Size by Type
Table 2017-2027 United States Neuromyelitis Optica Drug Market Size
Table 2017-2027 Canada Neuromyelitis Optica Drug Market Size
Table 2017-2027 Mexico Neuromyelitis Optica Drug Market Size
Table 2017-2027 South America Neuromyelitis Optica Drug Market Size
Figure 2017-2027 South America Neuromyelitis Optica Drug Market Size and CAGR
Table 2017-2027 South America Neuromyelitis Optica Drug Market Size by Application
Table 2017-2022 South America Neuromyelitis Optica Drug Key Players Revenue
Table 2017-2022 South America Neuromyelitis Optica Drug Key Players Market Share
Table 2017-2027 South America Neuromyelitis Optica Drug Market Size by Type
Table 2017-2027 Brazil Neuromyelitis Optica Drug Market Size
Table 2017-2027 Argentina Neuromyelitis Optica Drug Market Size
Table 2017-2027 Chile Neuromyelitis Optica Drug Market Size
Table 2017-2027 Peru Neuromyelitis Optica Drug Market Size
Table 2017-2027 Asia & Pacific Neuromyelitis Optica Drug Market Size
Figure 2017-2027 Asia & Pacific Neuromyelitis Optica Drug Market Size and CAGR
Table 2017-2027 Asia & Pacific Neuromyelitis Optica Drug Market Size by Application
Table 2017-2022 Asia & Pacific Neuromyelitis Optica Drug Key Players Revenue
Table 2017-2022 Asia & Pacific Neuromyelitis Optica Drug Key Players Market Share
Table 2017-2027 Asia & Pacific Neuromyelitis Optica Drug Market Size by Type
Table 2017-2027 China Neuromyelitis Optica Drug Market Size
Table 2017-2027 India Neuromyelitis Optica Drug Market Size
Table 2017-2027 Japan Neuromyelitis Optica Drug Market Size
Table 2017-2027 South Korea Neuromyelitis Optica Drug Market Size
Table 2017-2027 Southeast Asia Neuromyelitis Optica Drug Market Size
Table 2017-2027 Australia Neuromyelitis Optica Drug Market Size
Table 2017-2027 Europe Neuromyelitis Optica Drug Market Size
Figure 2017-2027 Europe Neuromyelitis Optica Drug Market Size and CAGR
Table 2017-2027 Europe Neuromyelitis Optica Drug Market Size by Application
Table 2017-2022 Europe Neuromyelitis Optica Drug Key Players Revenue
Table 2017-2022 Europe Neuromyelitis Optica Drug Key Players Market Share
Table 2017-2027 Europe Neuromyelitis Optica Drug Market Size by Type
Table 2017-2027 Germany Neuromyelitis Optica Drug Market Size
Table 2017-2027 France Neuromyelitis Optica Drug Market Size
Table 2017-2027 United Kingdom Neuromyelitis Optica Drug Market Size
Table 2017-2027 Italy Neuromyelitis Optica Drug Market Size
Table 2017-2027 Spain Neuromyelitis Optica Drug Market Size
Table 2017-2027 Belgium Neuromyelitis Optica Drug Market Size
Table 2017-2027 Netherlands Neuromyelitis Optica Drug Market Size
Table 2017-2027 Austria Neuromyelitis Optica Drug Market Size
Table 2017-2027 Poland Neuromyelitis Optica Drug Market Size
Table 2017-2027 Russia Neuromyelitis Optica Drug Market Size
Table 2017-2027 MEA Neuromyelitis Optica Drug Market Size
Figure 2017-2027 MEA Neuromyelitis Optica Drug Market Size and CAGR
Table 2017-2027 MEA Neuromyelitis Optica Drug Market Size by Application
Table 2017-2022 MEA Neuromyelitis Optica Drug Key Players Revenue
Table 2017-2022 MEA Neuromyelitis Optica Drug Key Players Market Share
Table 2017-2027 MEA Neuromyelitis Optica Drug Market Size by Type
Table 2017-2027 Egypt Neuromyelitis Optica Drug Market Size
Table 2017-2027 Israel Neuromyelitis Optica Drug Market Size
Table 2017-2027 South Africa Neuromyelitis Optica Drug Market Size
Table 2017-2027 Gulf Cooperation Council Countries Neuromyelitis Optica Drug Market Size
Table 2017-2027 Turkey Neuromyelitis Optica Drug Market Size
Table 2017-2022 Global Neuromyelitis Optica Drug Market Size by Region
Table 2017-2022 Global Neuromyelitis Optica Drug Market Size Share by Region
Table 2017-2022 Global Neuromyelitis Optica Drug Market Size by Application
Table 2017-2022 Global Neuromyelitis Optica Drug Market Share by Application
Table 2017-2022 Global Neuromyelitis Optica Drug Key Vendors Revenue
Figure 2017-2022 Global Neuromyelitis Optica Drug Market Size and Growth Rate
Table 2017-2022 Global Neuromyelitis Optica Drug Key Vendors Market Share
Table 2017-2022 Global Neuromyelitis Optica Drug Market Size by Type
Table 2017-2022 Global Neuromyelitis Optica Drug Market Share by Type
Table 2022-2027 Global Neuromyelitis Optica Drug Market Size by Region
Table 2022-2027 Global Neuromyelitis Optica Drug Market Size Share by Region
Table 2022-2027 Global Neuromyelitis Optica Drug Market Size by Application
Table 2022-2027 Global Neuromyelitis Optica Drug Market Share by Application
Table 2022-2027 Global Neuromyelitis Optica Drug Key Vendors Revenue
Figure 2022-2027 Global Neuromyelitis Optica Drug Market Size and Growth Rate
Table 2022-2027 Global Neuromyelitis Optica Drug Key Vendors Market Share
Table 2022-2027 Global Neuromyelitis Optica Drug Market Size by Type
Table 2022-2027 Neuromyelitis Optica Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer
  • Fresenius
  • TEVA
  • Sandoz
  • Intas
  • Gyjtrs
  • Nang Kuang
  • Tianjin Kingyork
  • Baxter
  • CSL

Methodology

Loading
LOADING...

Related Topics

Related Reports

Neuromyelitis Optica - Pipeline Insight, 2024 - Product Image

Neuromyelitis Optica - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2024 - Product Image

Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2024

  • Clinical Trials
  • 50 Pages
  • Global
From
Global Neuromyelitis Optica Spectrum Disorder Market 2023-2027 - Product Image

Global Neuromyelitis Optica Spectrum Disorder Market 2023-2027

  • Report
  • 138 Pages
  • Global
From
Global Central Nervous System Therapeutics Market Report by Disease, Application, and Region 2024-2032 - Product Image

Global Central Nervous System Therapeutics Market Report by Disease, Application, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Global Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Image

Global Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.